|
Vaneeva A.S., Ivshina A.V., Filimonova O.G.
Assessment of risk factors for osteoporosis in patients with osteoarthritis
|
№2 / 2024
|
|
L.V. Vasilyeva, E.V. Gosteva, E.F. Evstratova, E.Yu. Suslova
Experience of successful use of a combination of methylsulfonylmethane, vitamin C and native collagen-2 in a patient with osteoarthritis of the knee joints on the background of obesity: a clinical case
|
№1-2 / 2023
|
|
D.Yu. Andriyashkina, A.A. Klimenko, N.A. Demidova, A.A. Kondrashov, M.O. Anischenko
Delayed-release drugs for the treatment of knee osteoarthritis – drugs of choice in a comorbid patient
|
№1-2 / 2023
|
|
A.A. Kostromina, Yu.R. Khvostantseva, O.G. Filimonova
Dependence of clinical parameters on the presence of arterial hypertension in patients with osteoarthritis
|
№13 / 2022
|
|
I.V. Menshikova
Efficacy of the combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of osteoarthritis in multimorbid patients
|
№13 / 2022
|
|
I.A. Zolotovskaya, I.L. Davydkin
ANTIRESORPTIVE-CYTOCIN EFFICIENCY OF CHONDROPROTECTIVE THERAPY OF OSTEOARTHRITIS AND NON-SPECIFIC LOW BACK PAIN (RESULTS OF ALBATROS STUDY)
|
№19 / 2017
|
|
N.V. Chichasova
MODERN APPROACHES TO TREATMENT OF OSTEOARTHRITIS: THE ROLE OF INJECTABLE SLOW-ACTING SYMPTOM-MODIFIING PREPARATIONS
|
№19 / 2017
|
|
I.O. Smitienko (1), P.I. Novikov (2)
MODERN VIEW ON THE ANALGESIC DRUGS FOR OSTEOARTHRITIS: EVIDENCE FROM META-ANALYSIS ON THE EFFECTIVENESS
|
№19 / 2016
|
|
L.V. Vasilieva, E.F. Evstratova, A.V. Nikitin
EFFICACY OF TREATMENT WITH GLUCOSAMINE SULFATE (SUSTAGUARD ARTRO) IN PATIENTS WITH OSTEOARTHRITIS IN THE OUTPATIENT SETTINGS
|
№13 / 2016
|
|
N.A. Hitrov
THE LOCAL TREATMENT OPTIONS FOR OSTEOARTHROSIS
|
№16 / 2015
|
|
N.A. KHITROV
OSTEOARTHROSIS AND OSTEOARTHRITIS - FROM NEW VIEWS OF PATHOGENESIS TO A NEW DENOMINATION
|
№s4-13 / 2013
|
Русский
